Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

Open Access 01-12-2021 | Heart Surgery | Research

Effects of peak time of myocardial injury biomarkers on mid-term outcomes of patients undergoing OPCABG

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Background

With the development of cardiac surgery techniques, myocardial injury is gradually reduced, but cannot be completely avoided. Myocardial injury biomarkers (MIBs) can quickly and specifically reflect the degree of myocardial injury. Due to various reasons, there is no consensus on the specific values of MIBs in evaluating postoperative prognosis. This retrospective study was aimed to investigate the impact of MIBs on the mid-term prognosis of patients undergoing off-pump coronary artery bypass grafting (OPCABG).

Methods

Totally 564 patients undergoing OPCABG with normal courses were included. Cardiac troponin T (cTnT) and creatine kinase myocardial band (CK-MB) were assessed within 48 h before operation and at 6, 12, 24, 48, 72, 96 and 120 h after operation. Patients were grouped by peak values and peak time courses of MIBs. The profile of MIBs and clinical variables as well as their correlations with mid-term prognosis were analyzed by univariable and multivariable Cox regression models.

Result

Continuous assessment showed that MIBs increased first (12 h after surgery) and then decreased. The peak cTnT and peak CK-MB occurred within 24 h after operation in 76.8% and 67.7% of the patients respectively. No significant correlation was found between CK-MB and mid-term mortality. Delayed cTnT peak (peak cTnT elevated after 24 h after operation) was correlated with lower creatinine clearance rate (69.36 ± 21.67 vs. 82.18 ± 25.17 ml/min/1.73 m2), body mass index (24.35 ± 2.58 vs. 25.27 ± 3.26 kg/m2), less arterial grafts (1.24 ± 0.77 vs. 1.45 ± 0.86), higher EuroSCORE II (2.22 ± 1.12 vs.1.72 ± 0.91) and mid-term mortality (26.5 vs.7.9%). Age (HR: 1.067, CI: 1.006–1.133), left ventricular ejection fraction (HR: 0.950, CI: 0.910–0.993), New York Heart Association score (HR: 1.839, CI: 1.159–2.917), total venous grafting (HR: 2.833, CI: 1.054–7.614) and cTnT peak occurrence within 24 h (HR: 0.362, CI: 0.196–0.668) were independent predictors of mid-term mortality.

Conclusion

cTnT is a better indicator than CK-MB. The peak value and peak occurrence of cTnT are related to mid-term mortality in patients undergoing OPCABG, and the peak phases have stronger predictive ability. Trial registration: Chinese Clinical Trial Registry, ChiCTR2000033850. Registered 14 June 2020, http://​www.​chictr.​org.​cn/​edit.​aspx?​pid=​55162&​htm=​4.
Literature
1.
go back to reference Shengshou Hu, Runlin G, Lisheng L, et al. Report on cardiovascular diseases in China 2016. Beijing, China: Encyclopedia of China Publishing House; 2017. p. 210. Shengshou Hu, Runlin G, Lisheng L, et al. Report on cardiovascular diseases in China 2016. Beijing, China: Encyclopedia of China Publishing House; 2017. p. 210.
2.
go back to reference Carrier M, Pellerin M, Perrault LP, Solymoss BC, Pelletier LC. Troponin levels in patients with myocardial infarction after coronary artery bypass grafting. Ann Thorac Surg. 2000;69(2):435–40.CrossRef Carrier M, Pellerin M, Perrault LP, Solymoss BC, Pelletier LC. Troponin levels in patients with myocardial infarction after coronary artery bypass grafting. Ann Thorac Surg. 2000;69(2):435–40.CrossRef
3.
go back to reference Fransen EJ, Diris JH, Maessen JG, Hermens WT, van Dieijen-Visser MP. Evaluation of “new” cardiac markers for ruling out myocardial infarction after coronary artery bypass grafting. Chest. 2002;122(4):1316–21.CrossRef Fransen EJ, Diris JH, Maessen JG, Hermens WT, van Dieijen-Visser MP. Evaluation of “new” cardiac markers for ruling out myocardial infarction after coronary artery bypass grafting. Chest. 2002;122(4):1316–21.CrossRef
4.
go back to reference Lehrke S, Steen H, Sievers HH, et al. Cardiac troponin T for prediction of short- and long-term morbidity and mortality after elective open heart surgery. Clin Chem. 2004;50(9):1560–7.CrossRef Lehrke S, Steen H, Sievers HH, et al. Cardiac troponin T for prediction of short- and long-term morbidity and mortality after elective open heart surgery. Clin Chem. 2004;50(9):1560–7.CrossRef
5.
go back to reference Peivandi AA, Dahm M, Opfermann UT, et al. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction. Herz. 2004;29(7):658–64.CrossRef Peivandi AA, Dahm M, Opfermann UT, et al. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction. Herz. 2004;29(7):658–64.CrossRef
6.
go back to reference Mehdiani A, Akhyari P, Kamiya H, et al. Prognostic value of the new high sensitive cardiac troponin T assay (hs-cTnT) after coronary artery bypass grafting. Acta Cardiol. 2017;72(3):276–83.CrossRef Mehdiani A, Akhyari P, Kamiya H, et al. Prognostic value of the new high sensitive cardiac troponin T assay (hs-cTnT) after coronary artery bypass grafting. Acta Cardiol. 2017;72(3):276–83.CrossRef
7.
go back to reference Søraas CL, Friis C, Engebretsen KV, Sandvik L, Kjeldsen SE, Tønnessen T. Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery. Am Heart J. 2012;164(5):779–85.CrossRef Søraas CL, Friis C, Engebretsen KV, Sandvik L, Kjeldsen SE, Tønnessen T. Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery. Am Heart J. 2012;164(5):779–85.CrossRef
8.
go back to reference Carlsson AC, Bandstein N, Roos A, Hammarsten O, Holzmann MJ. High-sensitivity cardiac troponin T levels in the emergency department in patients with chest pain but no myocardial infarction. Int J Cardiol. 2017;228:253–9.CrossRef Carlsson AC, Bandstein N, Roos A, Hammarsten O, Holzmann MJ. High-sensitivity cardiac troponin T levels in the emergency department in patients with chest pain but no myocardial infarction. Int J Cardiol. 2017;228:253–9.CrossRef
9.
go back to reference Ge W, Gu C, Chen C, et al. High-sensitivity troponin T release profile in off-pump coronary artery bypass grafting patients with normal postoperative course. BMC Cardiovasc Disord. 2018;18(1):157.CrossRef Ge W, Gu C, Chen C, et al. High-sensitivity troponin T release profile in off-pump coronary artery bypass grafting patients with normal postoperative course. BMC Cardiovasc Disord. 2018;18(1):157.CrossRef
10.
go back to reference Chung JZ, Dallas Jones GR. Effect of renal function on serum cardiac troponin T-Population and individual effects. Clin Biochem. 2015;48(12):807–10.CrossRef Chung JZ, Dallas Jones GR. Effect of renal function on serum cardiac troponin T-Population and individual effects. Clin Biochem. 2015;48(12):807–10.CrossRef
11.
go back to reference Liu J, Zhang W, Wang Q, et al. The early diagnostic value of procalcitonin in pneumonia after off-pump coronary artery bypass grafting surgery. Med Sci Monit Int Med J Exp Clin Res. 2019;25:3077–89. Liu J, Zhang W, Wang Q, et al. The early diagnostic value of procalcitonin in pneumonia after off-pump coronary artery bypass grafting surgery. Med Sci Monit Int Med J Exp Clin Res. 2019;25:3077–89.
12.
go back to reference Arora RC, Singal RK. Is routine use of renal injury biomarkers in cardiac surgery patients putting the cart before the horse? J Thorac Cardiovasc Surg. 2017;154(3):938–9.CrossRef Arora RC, Singal RK. Is routine use of renal injury biomarkers in cardiac surgery patients putting the cart before the horse? J Thorac Cardiovasc Surg. 2017;154(3):938–9.CrossRef
13.
go back to reference Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–64.CrossRef Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–64.CrossRef
14.
go back to reference Kouvelos GN, Milionis HJ, Arnaoutoglou EM, et al. Postoperative levels of cardiac troponin versus CK-MB and high-sensitivity C-reactive protein for the prediction of 1-year cardiovascular outcome in patients undergoing vascular surgery. Coron Artery Dis. 2011;22(6):428–34.CrossRef Kouvelos GN, Milionis HJ, Arnaoutoglou EM, et al. Postoperative levels of cardiac troponin versus CK-MB and high-sensitivity C-reactive protein for the prediction of 1-year cardiovascular outcome in patients undergoing vascular surgery. Coron Artery Dis. 2011;22(6):428–34.CrossRef
15.
go back to reference Tevaearai Stahel HT, Do PD, Klaus JB, et al. Clinical relevance of troponin t profile following cardiac surgery. Front Cardiovasc Med. 2018;5:182.CrossRef Tevaearai Stahel HT, Do PD, Klaus JB, et al. Clinical relevance of troponin t profile following cardiac surgery. Front Cardiovasc Med. 2018;5:182.CrossRef
16.
go back to reference Nesher N, Alghamdi AA, Singh SK, et al. Troponin after cardiac surgery: a predictor or a phenomenon? Ann Thorac Surg. 2008;85(4):1348–54.CrossRef Nesher N, Alghamdi AA, Singh SK, et al. Troponin after cardiac surgery: a predictor or a phenomenon? Ann Thorac Surg. 2008;85(4):1348–54.CrossRef
17.
go back to reference Lurati Buse GA, Bolliger D, Seeberger E, et al. Troponin T and B-type natriuretic peptide after on-pump cardiac surgery: prognostic impact on 12-month mortality and major cardiac events after adjustment for postoperative complications. Circulation. 2014;130(12):948–57.CrossRef Lurati Buse GA, Bolliger D, Seeberger E, et al. Troponin T and B-type natriuretic peptide after on-pump cardiac surgery: prognostic impact on 12-month mortality and major cardiac events after adjustment for postoperative complications. Circulation. 2014;130(12):948–57.CrossRef
18.
go back to reference Sadony V, Körber M, Albes G, et al. Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg. 1998;13(1):57–65.CrossRef Sadony V, Körber M, Albes G, et al. Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg. 1998;13(1):57–65.CrossRef
19.
go back to reference Weidenmann V, Robinson NB, Rong LQ, et al. Diagnostic dilemma of perioperative myocardial infarction after coronary artery bypass grafting: a review. Int J Surg. 2020;79:76–83.CrossRef Weidenmann V, Robinson NB, Rong LQ, et al. Diagnostic dilemma of perioperative myocardial infarction after coronary artery bypass grafting: a review. Int J Surg. 2020;79:76–83.CrossRef
20.
go back to reference Li X, Shan L, Lv M, et al. Predictive ability of EuroSCORE II integrating cardiactroponin T in patients undergoing OPCABG. BMC Cardiovasc Disord. 2020;20(1):463.CrossRef Li X, Shan L, Lv M, et al. Predictive ability of EuroSCORE II integrating cardiactroponin T in patients undergoing OPCABG. BMC Cardiovasc Disord. 2020;20(1):463.CrossRef
21.
go back to reference Tsung JS, Tsung SS. Creatine kinase isoenzymes in extracts of various human skeletal muscles. Clin Chem. 1986;32(8):1568–70.CrossRef Tsung JS, Tsung SS. Creatine kinase isoenzymes in extracts of various human skeletal muscles. Clin Chem. 1986;32(8):1568–70.CrossRef
22.
go back to reference Vikenes K, Andersen KS, Melberg T, Farstad M, Nordrehaug JE. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms. Am J Cardiol. 2010;106(6):780–6.CrossRef Vikenes K, Andersen KS, Melberg T, Farstad M, Nordrehaug JE. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms. Am J Cardiol. 2010;106(6):780–6.CrossRef
Metadata
Title
Effects of peak time of myocardial injury biomarkers on mid-term outcomes of patients undergoing OPCABG
Publication date
01-12-2021
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-02006-5

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue